Panzani R C, Schiavino D, Nucera E, Pellegrino S, Fais G, Schinco G, Patriarca G
Laboratoire de Recherches Marseille, France.
Int Arch Allergy Immunol. 1995 May-Jun;107(1-3):251-4. doi: 10.1159/000236994.
Fifty-one patients presenting a dermatological allergy (erythema, urticaria, angioedema, contact dermatitis) to nickel were treated over 3 years with oral doses of 0.1 ng nickel sulfate per day, following a low-nickel diet. Diagnostic tests comprised patch and oral provocation tests. In 7 cases, the treatment was interrupted because of symptom reactivation, and in 14 cases for other reasons. Among the 30 cases who went through the whole follow-up, symptomatology totally disappeared in 29 cases, and a partial alleviation was achieved in 1 case after 1 year of treatment. Oral provocation tests with these 30 patients showed an overall increase of tolerance. Patch tests showed no variation in 20 cases, a diminution in 5, and were negative in 5. Although the study was not conducted double blind, the results of this attempt to cure nickel allergy are statistically significant.
51名对镍有皮肤过敏反应(红斑、荨麻疹、血管性水肿、接触性皮炎)的患者,在遵循低镍饮食的情况下,每天口服0.1纳克硫酸镍,持续治疗3年。诊断测试包括斑贴试验和口服激发试验。7例患者因症状复发而中断治疗,14例因其他原因中断治疗。在完成整个随访的30例患者中,29例症状完全消失,1例在治疗1年后症状部分缓解。对这30例患者进行的口服激发试验显示耐受性总体有所提高。斑贴试验结果显示,20例无变化,5例减轻,5例为阴性。尽管该研究并非双盲进行,但此次治愈镍过敏尝试的结果具有统计学意义。